Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Cyclerion Therapeutics (CYCN) over the last 4 years, with Q2 2025 value amounting to $1.3 million.

  • Cyclerion Therapeutics' Other Operating Expenses changed N/A to $1.3 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Cyclerion Therapeutics reported Other Operating Expenses of $1.3 million as of Q2 2025.
  • In the past 5 years, Cyclerion Therapeutics' Other Operating Expenses ranged from a high of $3.3 million in Q3 2023 and a low of -$881000.0 during Q2 2021
  • Moreover, its 3-year median value for Other Operating Expenses was $1.3 million (2025), whereas its average is $1.2 million.